Skip to main content
Table of Contents
Print

Do physicians measure cannabis blood levels in trials for sleep apnoea? 

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Clinical trials investigating cannabis for obstructive sleep apnoea (OSA)  often include careful measurement of cannabis blood levels in trials. Monitoring blood concentrations helps researchers understand safety, dosing, and potential efficacy. By tracking THC plasma monitoring, clinicians can evaluate how cannabinoids interact with the body, while pharmacokinetics in OSA of cannabis provides insights into absorption, metabolism, and elimination patterns. 

Monitoring Blood Levels in Research 

Before looking at specific methods, it is important to note that measuring cannabis blood levels in trials is a standard practice in well-designed studies. Accurate tracking ensures patient safety and reliable interpretation of results. 

Plasma concentration tracking 

Researchers regularly measure THC and other cannabinoids in the blood. This cannabis blood levels in trials approach helps determine optimal dosing for both efficacy and safety. 

Timing and frequency 

Frequent sampling allows investigators to observe fluctuations and peak effects. Understanding THC plasma monitoring patterns ensures that cannabinoids are administered safely during the study. 

Linking to clinical outcomes 

Blood level measurements are correlated with sleep improvements and symptom changes. Studying pharmacokinetics in OSA of cannabis helps researchers identify which concentrations are most likely to support therapeutic effects. 

In summary, measuring cannabis blood levels in trials is essential for understanding safety, dosing, and effectiveness. This careful monitoring allows clinicians and researchers to develop informed guidance for potential use in OSA treatment. 

If you’re exploring cannabis treatment options for obstructive sleep apnoea, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Obstructive Sleep Apnoea . 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories